Given the proliferation of medical devices over the past couple of decades, it’s easy to assume that there’s a technology solution for every disease and condition with any significant market size. Given the dozens if not hundreds of companies working on novel applications in everything from spine to heart valves, what untapped markets could possibly remain? Even a relatively new area, renal denervation, has, by some estimates, more than 60 technologies in development. Is there any serious condition that hasn’t yet attracted the attention of some device company and its investors?
Yes, say executives of New Jersey-based CircuLite Inc., makers of a novel implantable pump designed to treat a large group...
